Investors in Health

Lightrock is a global investment platform dedicated to building a sustainable future. Headquartered in London, Lightrock manages capital across both public and private markets, a significant portion of which is dedicated to climate innovation.

InHealth Ventures (IHV) is a London-based early stage venture capital fund investing in tech-enabled healthcare and life sciences. We back founders working to reengineer healthcare, and use our deep experience, strategic insights and global network to accelerate their journey from Seed to Series A and beyond. IHV’s mission is to contribute to bending the healthcare cost curve, improving patient access and outcomes while enhancing the working lives of clinical and non-clinical staff.

We support founders with our unique ecosystem and a clear mission to bring together the next generation of great entrepreneurs. We seek out those who challenge the status quo, who see opportunities where others see barriers. We're committed to empowering the most innovative minds, providing not just funding, but mentorship, guidance, and a network that fuels their growth.

Qbic is a seed and early-stage venture capital fund supporting spin-offs and start-ups that valorize research from Qbic's knowledge partners. Qbic is one of the largest spin-off funds in Europe managing €190 million in resources over the different funds. Qbic I launched in 2012 and has finalized its portfolio of 18 ventures; Qbic II launched in 2017 and has a portfolio of 19 ventures, and Qbic III launched in 2022 and is currently building its portfolio.

At PUSH, we are committed to combat climate change and transform healthcare. Our initial investments are typically at pre-seed or seed stage with the potential to follow-on. Focus areas are health and future of the planet in Europe, especially Austria and Germany.

Allianz X invests in digital frontrunners in ecosystems relevant to insurance and asset management. In just a few years, it has grown to a portfolio of more than 25 companies and AuM of over 1.5 billion euros. Allianz X has counted 12 unicorns among its portfolio so far. The heart and brains behind it all are a talented team of around 40 people. As one of the pillars of the Allianz Group’s digital transformation strategy, Allianz X provides an interface between Allianz Operating Entities and the broader digital ecosystem, enabling collaborative partnerships in insurtech, fintech, and beyond. As an investor, Allianz X supports mature digital growth companies to take the next bold leap and reach their full potential.

AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage software, healthcare and deeptech companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which is authorised and regulated by the Financial Conduct Authority.

212 backs bold, growth-stage tech companies across Turkey, CEE, MENA and the diaspora. Currently, the fund manages €86M of committed capital and 19 active investments. 212’s time-tested strategy is to advance B2B tech solutions with demonstrated traction, a precise product-market fit, and founders who are ready and eager to scale internationally. As a firm believer in investing in teams, 212 has built a diverse and dynamic team over a decade while establishing and utilizing a robust presence in Istanbul, Doha, and San Francisco. ‘Test Local, Go Global’ is 212’s guiding principle. 212 does more than invest in the region and aims higher than going global. It is a personalized venture capital firm with deeply rooted global networks that bring in growth partners to help expand and guide the ecosystem. The forward-thinking initiative ‘212 Growth Partner’ program is one initiative that supports and provides value-add services to portfolio companies. Over two funds, 212 has created +$2B in value investing in early-stage technology startups. Acclaimed winners from Fund I include Iyzico and Insider. Iyzico exited in 2019, returning the fund’s entire invested capital. Insider, a Sequoia-backed company with a female founder, is the first B2B unicorn to come out of Turkey. To date, Fund II has invested in 16 remarkable companies: 123 Form Builder, App Samurai, Artboard Studio, Avatao, Chooch, Fazla, MallIQ, Marti, Meddy, Metrobi, OMMA, SmartMessage, Trio Mobil, Bolt, Wellbees and Socradar.

Unruly invests in founders that leverage industrial decentralization to create abundance, resilience and freedom - bringing about a more decarbonized, decentralized and developed world.

Creathor Ventures invests in technology-oriented companies that drive the automation of industry and business, and the personalization and digitalization of healthcare. The regional focus is on Germany and Switzerland. From its locations in Bad Homburg and Zurich, the team currently supports over 30 tech and healthcare companies. Over the past 30 years, the management team has financed over 200 companies as lead or co-lead investors. More than 20 companies have been listed on international stock exchanges. Creathor Ventures currently manages a fund volume of over 230 million euros.

Embryo Ventures is a London-based venture firm that backs visionary founders building transformational companies at the seed stage. We place relationships at the fore and are committed to bringing powerful ideas that purposefully challenge current thinking and practice to life.